[
    [
        {
            "time": "",
            "original_text": "【首发】睿笛生物宣布完成数亿元B轮融资，用于开展临床试验，扩展新产品线及市场开拓",
            "features": {
                "keywords": [
                    "睿笛生物",
                    "B轮融资",
                    "临床试验",
                    "新产品线",
                    "市场开拓"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物科技",
                    "医疗健康"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "【首发】睿笛生物宣布完成数亿元B轮融资，用于开展临床试验，扩展新产品线及市场开拓",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 10
            }
        }
    ]
]